Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Kissei Pharmaceutical submits NDA in Japan for PA-21

Nov. 20, 2014

Daiichi Sankyo patents new phosphate transporter inhibitors

Nov. 12, 2014

PBI-4050 cleared to commence trials in patients with diabetic kidney disease

Nov. 12, 2014

Novel cystine derivatives inhibit stone formation in vivo

Nov. 7, 2014

Nymox's NX-1207 fails to achieve efficacy endpoints in phase III BPH trials

Nov. 3, 2014

Relypsa submits NDA to FDA seeking approval of patiromer for hyperkalemia

Oct. 23, 2014

Cardiotrophin-1 granted FDA orphan designation for use in kidney transplantation

Oct. 22, 2014

Fispemifene licensed to Apricus Biosciences

Oct. 21, 2014

Topline results reported from phase IIa study of LPCN-1111

Oct. 14, 2014

Patient enrollment under way in phase II trial of VPI-2690B in diabetic nephropathy

Oct. 9, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...